Bright Minds Biosciences Working Capital Growth & History (DRUG)
Bright Minds Biosciences's working capital was $82.0M for fiscal 2025.
View full Bright Minds Biosciences company overviewBright Minds Biosciences annual working capital history
| Fiscal year | Period ended | Working capital | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-09-30 | $82.0M | $76.5M | +1401.84% |
| 2024 | 2024-09-30 | $5.5M | −$1.1M | −16.44% |
| 2023 | 2023-09-30 | $6.5M | −$3.9M | −37.65% |
| 2022 | 2022-09-30 | $10.5M | −$8.9M | −46.00% |
| 2021 | 2021-09-30 | $19.4M | — | — |
Bright Minds Biosciences quarterly working capital
| Fiscal quarter | Period ended | Working capital | Change | YoY change |
|---|---|---|---|---|
| Q3 2026 | 2026-06-30 | $307.7M | $256.0M | +494.51% |
| Q2 2026 | 2026-03-31 | $308.5M | $252.8M | +454.02% |
| Q1 2026 | 2025-12-31 | $89.2M | — | — |
| Q4 2025 | 2025-09-30 | $82.0M | $76.5M | +1401.84% |
| Q3 2025 | 2025-06-30 | $51.8M | — | — |
| Q2 2025 | 2025-03-31 | $55.7M | — | — |
| Q4 2024 | 2024-09-30 | $5.5M | −$1.1M | −16.44% |
| Q4 2023 | 2023-09-30 | $6.5M | −$3.9M | −37.65% |
| Q4 2022 | 2022-09-30 | $10.5M | −$8.9M | −46.00% |
| Q4 2021 | 2021-09-30 | $19.4M | — | — |
Bright Minds Biosciences working capital trends
Between the periods ended 2021-09-30 and 2025-09-30, Bright Minds Biosciences's working capital increased from $19.4M to $82.0M, a change of $62.6M. The latest reported quarter, Q3 2026, shows $307.7M.
What working capital means
Working capital is the difference between current assets and current liabilities. It provides a snapshot of short-term operating liquidity, although negative working capital can be normal for some business models and the measure is often not meaningful for banks.
How working capital is calculated
TickerStat calculates working capital as reported current assets minus reported current liabilities at the same balance-sheet date. Missing current classifications are not assumed to be zero. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Bright Minds Biosciences source filings ↗